Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Cited by (1,000)

Items 201–300 of 1,000

1. Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia
   Josep Saura, Ester Angulo-Pueyo, Aroa Ejarque-Ortiz, Vicent Casadó, Josep M. Tusell, Rosario Moratalla, Jiang‐Fan Chen, Michael A. Schwarzschild, Carme Lluı́s, Rafael Franco et al. · 2005 · Journal of Neurochemistry
2. Melatonin role in the mitochondrial function
   Darı́o Acuña-Castroviejo · 2006 · Frontiers in bioscience
3. Neuroprotective effect of nicotine on dopaminergic neurons by anti‐inflammatory action
   Hyun-Jung Park, Phil Hyu Lee, Young Whan Ahn, Yun Jung Choi, Gwang Lee, Da‐Yong Lee, Eun S. Chung, Byung Kwan Jin · 2007 · European Journal of Neuroscience
4. Chondroitin Sulfate Proteoglycans in the Nervous System: Inhibitors to Repair
   Justin R. Siebert, Amanda C. Conta, Donna J. Osterhout · 2014 · BioMed Research International
5. Of Pesticides and Men: a California Story of Genes and Environment in Parkinson’s Disease
   Beate R. Ritz, Kimberly C. Paul, Jeff M. Bronstein · 2016 · Current Environmental Health Reports
6. Oxidative Stress in Parkinson’s Disease: Potential Benefits of Antioxidant Supplementation
   Sandro Percário, Aline da Silva Barbosa, Everton Luiz Pompeu Varela, Antônio Rafael Quadros Gomes, Michelli Erica Souza Ferreira, Thayana de Nazaré Araújo Moreira, Maria Fâni Dolabela · 2020 · Oxidative Medicine and Cellular Longevity
7. Prevention of Nitric Oxide-Mediated 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson’s Disease in Mice by Tea Phenolic Epigallocatechin 3-Gallate
   Ji‐Young Choi, Chang‐Shin Park, Dae-Joong Kim, Myung‐Haing Cho, Byung-Kwan Jin, Jae-Eun Pie, Woon‐Gye Chung · 2002 · NeuroToxicology
8. Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration
   Andersen, Hjalte Holm, Johnsen, Kasper Bendix, Moos, Torben · 2014 · Cellular and Molecular Life Sciences
9. Redox Reactions Induced by Nitrosative Stress Mediate Protein Misfolding and Mitochondrial Dysfunction in Neurodegenerative Diseases
   Zezong Gu, Tomohiro Nakamura, Stuart A. Lipton · 2010 · Molecular Neurobiology
10. Quercetin and Sesamin Protect Dopaminergic Cells from MPP+-Induced Neuroinflammation in a Microglial (N9)-Neuronal (PC12) Coculture System
    Julie Bournival, Marilyn Plouffe, Justine Renaud, Cindy Provencher, Maria‐Grazia Martinoli · 2012 · Oxidative Medicine and Cellular Longevity
11. Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation
    Han-Qing Chen, Zhengyu Jin, Xijin Wang, Xueming Xu, Li Deng, Jian-Wei Zhao · 2008 · Neuroscience Letters
12. Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease
    Katharina Faust, Stephan Gehrke, Yufeng Yang, Lichuan Yang, M. Flint Beal, Bingwei Lu · 2009 · BMC Neuroscience
13. A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J mouse
    Zachary C. Baquet, D. Williams, J. Brody, Richard Jay Smeyne · 2009 · Neuroscience
14. Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease
    Hui‐Ming Gao, Bin Liu, Wanqin Zhang, Jau‐Shyong Hong · 2003 · The FASEB Journal
15. The role of neuroinflammation on the pathogenesis of Parkinson's disease
    Young Cheul Chung, Hyuk Wan Ko, Eugene Bok, Eun Su Park, Sue Hee Huh, Jin Han Nam, Byung Kwan Jin · 2010 · BMB Reports
16. Peroxynitrite and drug-dependent toxicity
    Ana Denicola, Rafael Radí · 2004 · Toxicology
17. TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson’s diseases in vivo model
    Michela Campolo, Irene Paterniti, Rosalba Siracusa, Alessia Filippone, Emanuela Esposito, Salvatore Cuzzocrea · 2018 · Brain Behavior and Immunity
18. Proteasome inhibition and Parkinson's disease modeling
    Jordi Bové, Chun Hui Zhou, Vernice R. Jackson-Lewis, Julie P. Taylor, Yaping Chu, Hardy J. Rideout, Du-Chu Wu, Jeffrey H. Kordower, Leonard Petrucelli, Serge Przedborski · 2006 · Annals of Neurology
19. Microglia expressing interleukin‐13 undergo cell death and contribute to neuronal survival in vivo
    Won H. Shin, Da‐Yong Lee, Keun Woo Park, Seung Up Kim, Myung‐Soon Yang, Eun-hye Joe, Byung Kwan Jin · 2004 · Glia
20. Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle
    Kristen A. Malkus, Elpida Tsika, Harry Ischiropoulos · 2009 · Molecular Neurodegeneration
21. Awareness and current knowledge of Parkinson’s disease: a neurodegenerative disorder
    Asmat Ullah Khan, Muhammad Akram, Muhammad Daniyal, Rida Zainab · 2018 · International Journal of Neuroscience
22. Glial Cells as Players in Parkinsonism: The “Good,” the “Bad,” and the “Mysterious” Glia
    María A. Mena, Justo Garcı́a de Yébenes · 2008 · The Neuroscientist
23. Striatal Neuroinflammation Promotes Parkinsonism in Rats
    Choi, Dong-Young, Liu, Mei, Hunter, Randy L., Cass, Wayne A., Pandya, Jignesh D., Sullivan, Patrick G., Shin, Eun-Joo, Kim, Hyoung-Chun, Gash, Don M., Bing, Guoying · 2009 · PLoS ONE
24. Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65
    Shohei Shinozaki, Kyungho Chang, Michihiro Sakai, Nobuyuki Shimizu, Marina Yamada, Tomokazu Tanaka, Harumasa Nakazawa, Fumito Ichinose, Yoshitsugu Yamada, Akihito Ishigami et al. · 2014 · Science Signaling
25. Chronic expression of low levels of tumor necrosis factor-α in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation
    Ana Laura De Lella Ezcurra, Mariela Chertoff, Carina Cintia Ferrari, Mariana Graciarena, Fernando Juan Pitossi · 2009 · Neurobiology of Disease
26. Caspase-11 Mediates Inflammatory Dopaminergic Cell Death in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson's Disease
    Tsuyoshi Furuya, Hideki Hayakawa, Masanori YAMADA, Kenji Yoshimi, Shin Hisahara, Masayuki Miura, Yoshikuni Mizuno, Hideki Mochizuki · 2004 · Journal of Neuroscience
27. The Role of Reactive Species on Innate Immunity
    Andrés, Celia, Pérez de la Lastra, José, Juan, Celia, Plou, Francisco, Pérez-Lebeña, Eduardo · 2022 · Vaccines
28. Chondroitin sulfate proteoglycan expression pattern in hippocampal development: Potential regulation of axon tract formation
    Mark T. Wilson, Diane M. Snow · 2000 · The Journal of Comparative Neurology
29. Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1receptor
    Hua‐Qing Liu, Wen Zhang, Xueting Luo, Ye Yang, Xing‐Zu Zhu · 2006 · British Journal of Pharmacology
30. Adrenomedullin and Nitric Oxide Inhibit Human Endothelial Cell Apoptosis via a Cyclic GMP-Independent Mechanism
    Masataka Sata, Masao Kakoki, Daisuke Nagata, Hiroaki Nishimatsu, Etsu Suzuki, Teruhiko Aoyagi, Seiryo Sugiura, Hirotatsu Kojima, Tetsuo Nagano, Kenji Kangawa et al. · 2000 · Hypertension
31. Identification of neurodegenerative factors using translatome–regulatory network analysis
    Brichta, Lars, Shin, William, Jackson-Lewis, Vernice, Blesa, Javier, Yap, Ee-Lynn, Walker, Zachary, Zhang, Jack, Roussarie, Jean-Pierre, Alvarez, Mariano J, Califano, Andrea et al. · 2015 · Nature Neuroscience
32. Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone
    Hayate Javed, Sheikh Azimullah, Salema B. Abul Khair, Shreesh Kumar Ojha, Md. Emdadul Haque · 2016 · BMC Neuroscience
33. Intranasal Administration of TAT-Conjugated Lipid Nanocarriers Loading GDNF for Parkinson’s Disease
    Sara Hernando, Enara Herrán, Joana Figueiro‐Silva, José Luís Pedraz, Manoli Igartúa, Eva Carro, Rosa Marı́a Hernández · 2017 · Molecular Neurobiology
34. Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons
    F.-Q. Li, T. Wang, Z. Pei, Bin Liu, Jau‐Shyong Hong · 2004 · Journal of Neural Transmission
35. Increased thalamic neurodegeneration following ischaemic cortical stroke in osteopontin-deficient mice.
    M. Schroeter, P. Zickler, D. Denhardt, H. Hartung, S. Jander · 2006 · Brain : a journal of neurology
36. Role of nitric oxide in rotenone‐induced nigro‐striatal injury
    Yi He, Syed Z. Imam, Zaojun Dong, Joseph J. Jankovic, Syed F. Ali, Stanley H. Appel, Weidong Le · 2003 · Journal of Neurochemistry
37. Nitric oxide as a physiopathological factor in neuropsychiatric disorders.
    Ömer Akyol, S. Salih Zoroğlu, Ferah Armutçu, Şemsettin Şahin, Ahmet Gürel · 2004 · PubMed
38. Mitochondrial alterations in Parkinson’s disease: new clues
    Miquel Vila, David Ramonet, Céline Perier · 2008 · Journal of Neurochemistry
39. Effects of Subchronic Exposures to Concentrated Ambient Particles: VII. Degeneration of Dopaminergic Neurons in Apo E−/−Mice
    Bellina Veronesi, Om Makwana, Melanie Pooler, Lung‐Chi Chen · 2005 · Inhalation Toxicology
40. MPTP
    Samuel G. Speciale · 2002 · Neurotoxicology and Teratology
41. Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson’s disease
    Michael D. Boska, Khader M. Hasan, Danette Kibuule, Rebecca Banerjee, Erin M. McIntyre, Jay A. Nelson, Theresa Hahn, Howard Eliot Gendelman, Rodney Lee Mosley · 2007 · Neurobiology of Disease
42. Aberrant Tonic Inhibition of Dopaminergic Neuronal Activity Causes Motor Symptoms in Animal Models of Parkinson’s Disease
    Heo, Jun Young, Nam, Min-Ho, Yoon, Hyung Ho, Kim, Jeongyeon, Hwang, Yu Jin, Won, Woojin, Woo, Dong Ho, Lee, Ji Ae, Park, Hyun-Jung, Jo, Seonmi et al. · 2020 · Current Biology
43. Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain
    Valentina G. Bashkatova, Mesbah Alam, Anatoly F. Vanin, Werner Schmidt · 2004 · Experimental Neurology
44. Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation
    Young Cheul Chung, Sang Ryong Kim, Ju Young Park, Eun S. Chung, Keun W. Park, So-Yoon Won, Eugene Bok, Minyoung Jin, Eun Su Park, Sung-Hwa Yoon · 2011 · Neuropharmacology
45. CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson’s disease
    Young Cheul Chung, Won-Ho Shin, Jeong Yeob Baek, Eun J. Cho, Hyung Hwan Baik, Sang Ryong Kim, So-Yoon Won, Byung Kwan Jin · 2016 · Experimental & Molecular Medicine
46. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production
    Tapias, Victor, Hu, Xiaoping, Luk, Kelvin C., Sanders, Laurie H., Lee, Virginia M., Greenamyre, J. Timothy · 2017 · Cellular and Molecular Life Sciences
47. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson’s disease
    Anamitra Ghosh, Arthi Kanthasamy, Joy Joseph, Vellareddy Anantharam, Pallavi Srivastava, Brian P. Dranka, Balaraman Kalyanaraman, Anumantha G. Kanthasamy · 2012 · Journal of Neuroinflammation
48. Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study
    Clotilde Lévecque · 2003 · Human Molecular Genetics
49. Macrophage Antigen Complex-1 Mediates Reactive Microgliosis and Progressive Dopaminergic Neurodegeneration in the MPTP Model of Parkinson’s Disease
    Xiaoming Hu, Dan Zhang, Hao Pang, William Michael Caudle, Yachen Li, Hui‐Ming Gao, Yuxin Liu, Qian Li, Belinda C. Wilson, Donato A. Di Monte et al. · 2008 · The Journal of Immunology
50. α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation
    Yuan Liu, Jun Hu, Jie Wu, Chenlei Zhu, Yujian Hui, Yaping Han, Zuhu Huang, Kevin R. Ellsworth, Weimin Fan · 2012 · Journal of Neuroinflammation
51. Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation
    Young Cheul Chung, Eugene Bok, Sue Hee Huh, Ju‐Young Park, Sung‐Hwa Yoon, Sang Ryong Kim, Yoon‐Seong Kim, Sungho Maeng, Sung Hyun Park, Byung Kwan Jin · 2011 · The Journal of Immunology
52. An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition
    EFSA WG EPI1 Members, Terron, Andrea, Bal-Price, Anna, Paini, Alicia, Monnet-Tschudi, Florianne, Bennekou, Susanne Hougaard, Leist, Marcel, Schildknecht, Stefan · 2018 · Archives of Toxicology
53. Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model
    Jun Mo Kang, Hi‐Joon Park, Yeong Gon Choi, Il‐Hwan Choe, Jae Hyun Park, Yong Sik Kim, Sabina Lim · 2006 · Brain Research
54. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis
    Adam Ian Kaplin · 2005 · Journal of Clinical Investigation
55. The acute and the long‐term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation
    Mahmoud M. Iravani, Clement C. M. Leung, Mona Sadeghian, Claire O. Haddon, Sarah Rose, Peter G. Jenner · 2005 · European Journal of Neuroscience
56. Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt
    Bin Xing, Tao Xin, Randy L. Hunter, Guoying Bing · 2008 · Journal of Neuroinflammation
57. Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson’s disease
    Young Cheul Chung, Jeong Yeob Baek, Sang Ryong Kim, Hyuk Wan Ko, Eugene Bok, Won-Ho Shin, So-Yoon Won, Byung Kwan Jin · 2017 · Experimental & Molecular Medicine
58. Inflaming the Brain with Iron
    Pamela J. Urrutia, Daniel A. Bórquez, M. Núñez · 2021 · Antioxidants
59. Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice
    Michael L. Selley · 2005 · Brain Research
60. Inducible Nitric-oxide Synthase and NO Donor Induce Insulin Receptor Substrate-1 Degradation in Skeletal Muscle Cells
    Hiroki Sugita, Masaki Fujimoto, Takashi Yasukawa, Nobuyuki Shimizu, Michiko Sugita, Shingo Yasuhara, J. A. Jeevendra Martyn, Masao Kaneki · 2005 · Journal of Biological Chemistry
61. Stimulation of the NADPH oxidase in activated rat microglia removes nitric oxide but induces peroxynitrite production
    Anna Bal‐Price, Anita Matthias, Guy Charles Brown · 2001 · Journal of Neurochemistry
62. Granulocyte‐colony stimulating factor is neuroprotective in a model of Parkinson's disease
    Katrin Meuer, Claudia Pitzer, Peter Teismann, Carola Krüger, Bettina Göricke, Rico Laage, Paul Lingor, Kerstin Peters, Johannes C. M. Schlachetzki, Kazuto Kobayashi et al. · 2006 · Journal of Neurochemistry
63. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease
    Byung-Wook Kim, Sushruta Koppula, Hemant Kumar, Ju‐Young Park, Il-Woung Kim, Sandeep Vasant More, In‐Su Kim, Sang-Don Han, Si‐Kwan Kim, Sung‐Hwa Yoon et al. · 2015 · Neuropharmacology
64. VMAT2 and dopamine neuron loss in a primate model of Parkinson’s disease
    Ming‐Kai Chen, Hiroto Kuwabara, Yun Zhou, Robert J. Adams, James Robert Brašić, Jennifer L. McGlothan, Tatyana Verina, Neal C. Burton, Mohab Alexander, Anil Kumar et al. · 2007 · Journal of Neurochemistry
65. Multiple actions of the chemokine stromal cell-derived factor-1α on neuronal activity
    Alice Guyon, Jean‐Louis Nahon · 2006 · Journal of Molecular Endocrinology
66. Neuroinflammation in Parkinson's Disease: Is there sufficient evidence for mechanism-based interventional therapy?
    Malú G. Tansey · 2007 · Frontiers in bioscience
67. Doxycycline restrains glia and confers neuroprotection in a 6‐OHDA Parkinson model
    Márcio Lazzarini, Sabine Martin, Mišo Mitkovski, Rita Raisman‐Vozari, Walter Stühmer, Elaine Del Bel · 2013 · Glia
68. Molecular Hydrogen as a Neuroprotective Agent
    Masumi Iketani, Ikuroh Ohsawa · 2016 · Current Neuropharmacology
69. GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice
    Lisa M. Kosloski, Elizabeth A. Kosmacek, Katherine E. Olson, Rodney Lee Mosley, Howard Eliot Gendelman · 2013 · Journal of Neuroimmunology
70. Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System
    Byung-Wook Kim, Kyoung Hoon Jeong, Jae‐Hong Kim, Myungwon Jin, Jong‐Heon Kim, Maan‐Gee Lee, Dong‐Kug Choi, So-Yoon Won, Catriona McLean, Min‐Tae Jeon et al. · 2016 · Journal of Neuroscience
71. Glial Dysfunction in Parkin Null Mice: Effects of Aging
    Rosa Maria Solano, Marı́a José Casarejos, Jamie Menéndez-Cuervo, José Antonio Rodríguez‐Navarro, Justo Garcı́a de Yébenes, María A. Mena · 2008 · Journal of Neuroscience
72. Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease
    Faucheux, Baptiste A., Martin, Marie‐Elise, Beaumont, Carole, Hunot, Stéphane, Hauw, Jean‐Jacques, Agid, Yves, Hirsch, Etienne C. · 2002 · Journal of Neurochemistry
73. ACSL4 promotes microglia-mediated neuroinflammation by regulating lipid metabolism and VGLL4 expression
    Xin Zhou, Rui Zhao, Mengfei Lv, Xiangyu Xu, Wenhao Liu, Xiaohua Li, Yunyi Gao, Zhiyuan Zhao, Zhaolong Zhang, Yuxuan Li et al. · 2023 · Brain Behavior and Immunity
74. Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases
    Tomohiro Nakamura, Dong‐Hyung Cho, Stuart A. Lipton · 2012 · Experimental Neurology
75. Nitric Oxide/Nitric Oxide Synthase System in the Pathogenesis of Neurodegenerative Disorders—An Overview
    Olga-Maria Iova, Gheorghe-Eduard Marin, Izabella Lazar, Ioana Stănescu, Gabriela Dogaru, Cristina Ariadna Nicula, Adriana Elena Bulboacă · 2023 · Antioxidants
76. MPP + ‐induced COX‐2 activation and subsequent dopaminergic neurodegeneration
    Tongguang Wang, Zhong Pei, Wei Zhang, Bin Liu, Robert I. Langenbach, Christopher Lee, Belinda C. Wilson, Jeffrey M. Reece, David S. Miller, Jau‐Shyong Hong · 2005 · The FASEB Journal
77. Peripheral Inflammation Enhances Microglia Response and Nigral Dopaminergic Cell Death in an in vivo MPTP Model of Parkinson’s Disease
    García-Domínguez, Irene, Veselá, Karolina, García-Revilla, Juan, Carrillo-Jiménez, Alejandro, Roca-Ceballos, María Angustias, Santiago, Marti, de Pablos, Rocío M., Venero, José L. · 2018 · Frontiers in Cellular Neuroscience
78. Inhibition of thrombin‐induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo
    Sang Ho Choi, Da Y. Lee, Eun S. Chung, Young Bin Hong, Seung Up Kim, Byung Kwan Jin · 2005 · Journal of Neurochemistry
79. Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease
    O Eberhardt · 2003 · Toxicology Letters
80. The role of thioredoxin in the regulation of cellular processes by S-nitrosylation
    Sengupta, Rajib, Holmgren, Arne · 2012 · Biochimica et Biophysica Acta (BBA) - General Subjects
81. Nitric oxide synthase regulation and diversity: Implications in Parkinson’s disease
    Ramkumar Kavya, Rohit Saluja, Sarika Singh, Madhu Dikshit · 2006 · Nitric Oxide
82. Reactive microgliosis: extracellular μ-calpain and microglia-mediated dopaminergic neurotoxicity
    Shannon Levesque, Belinda C. Wilson, Vincent Gregoria, Laura B. Thorpe, Shannon Dallas, Vadim S. Polikov, Jau‐Shyong Hong, Michelle L. Block · 2010 · Brain
83. Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson’s Disease
    Anamitra Ghosh, Monica Renee Langley, Dilshan S. Harischandra, Matthew P Neal, Huajun Jin, Vellareddy Anantharam, Joy Joseph, Timothy M. Brenza, Balaji Narasimhan, Arthi Kanthasamy et al. · 2016 · Journal of Neuroimmune Pharmacology
84. Baicalein attenuates astroglial activation in the 1‐methyl‐4‐phenyl‐1,2,3,4‐tetrahydropyridine‐induced Parkinson's disease model by downregulating the activations of nuclear factor‐κB, ERK, and JNK
    Eunjin Lee, Hee Ra Park, Seung Taek Ji, Yujeong Lee, Jaewon Lee · 2013 · Journal of Neuroscience Research
85. Melatonin and its brain metabolite N1‐acetyl‐5‐methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice
    Vı́ctor Tapias, Germaine Escames, Luis Carlos López, Ana López, Encarnación Camacho, María Dora Carriòn, Antonio Entrena, Miguel Á. Gallo, Antonio Espinosa, Darı́o Acuña-Castroviejo · 2009 · Journal of Neuroscience Research
86. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer’s and Parkinson’s diseases
    Tomohiro Nakamura, Stuart A. Lipton · 2010 · APOPTOSIS
87. Emerging Roles of S -Nitrosylation in Protein Misfolding and Neurodegenerative Diseases
    Tomohiro Nakamura, Stuart A. Lipton · 2007 · Antioxidants and Redox Signaling
88. Reactive Oxygen Species and Inhibitors of Inflammatory Enzymes, NADPH Oxidase, and iNOS in Experimental Models of Parkinson’s Disease
    Sushruta Koppula, Hemant Kumar, In Su Kim, Dong‐Kug Choi · 2012 · Mediators of Inflammation
89. The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease
    Kemal Uğur Tüfekçi, Şermin Genç, Kürşad Genç · 2011 · Parkinson s Disease
90. Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson’s disease
    Myung Sik Yoo, Hong Sung Chun, Jessica J. Son, Lorraine A. DeGiorgio, Dae Joon Kim, Chu Peng, Jin H. Son · 2003 · Molecular Brain Research
91. Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates
    Shigeki Arawaka, Hiroyasu Sato, Asuka Sasaki, Shingo Koyama, Takeo Kato · 2017 · Acta Neuropathologica Communications
92. Blood–Brain Barrier Permeable Photoacoustic Probe for High-Resolution Imaging of Nitric Oxide in the Living Mouse Brain
    Zhiyong Jiang, Zhaolun Liang, Yijing Cui, Changli Zhang, Jing Wang, Hong Wang, Tianzhu Wang, Yuncong Chen, Weijiang He, Zhipeng Liu et al. · 2023 · Journal of the American Chemical Society
93. Nitric oxide synthase genes and their interactions with environmental factors in Parkinson’s disease
    Dana B. Hancock, Eden R. Martin, Jeffery M. Vance, William K. Scott · 2008 · Neurogenetics
94. Nitrated α-Synuclein Induces the Loss of Dopaminergic Neurons in the Substantia Nigra of Rats
    Zhongwang Yu, Xiaohui Xu, Zhenghua Xiang, Jianfeng Zhou, Zhaohuan Zhang, Chun Hu, Cheng He · 2010 · PLoS ONE
95. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease
    Richard Gordon, Neeraj Singh, Vivek Lawana, Anamitra Ghosh, Dilshan S. Harischandra, Huajun Jin, Colleen Hogan, Souvarish Sarkar, Dharmin Rokad, Nikhil Panicker et al. · 2016 · Neurobiology of Disease
96. Nitric Oxide Triggers the Toxicity due to Glutathione Depletion in Midbrain Cultures through 12-Lipoxygenase
    Santiago Canals, Marı́a José Casarejos, Sonsoles de Bernardo, Eulalia Rodríguez‐Martín, María A. Mena · 2003 · Journal of Biological Chemistry
97. Delayed peripheral Nerve Degeneration, Regeneration, and pain in Mice Lacking Inducible Nitric Oxide Synthase
    Dan Levy, Paul Kubes, Douglas William Zochodne · 2001 · Journal of Neuropathology & Experimental Neurology
98. Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra
    Hey‐Kyeong Jeong, Ilo Jou, Eun-hye Joe · 2010 · Experimental & Molecular Medicine
99. Mitochondrial Dysfunction and Oxidative Stress in Parkinson’s Disease
    Isaac G. Onyango · 2007 · Neurochemical Research
100. Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease.
     C. Depboylu, S. Stricker, Jean-Pierre Ghobril, W. Oertel, Josef Priller, G. Höglinger · 2012 · Experimental Neurology